- What is KLOW?
- KLOW is a single compounded injectable combining four peptides: BPC-157 (associated with tissue repair), TB-500 (an N-acetylated seven-amino-acid fragment of thymosin beta-4, associated with cell migration), KPV (an alpha-MSH derived anti-inflammatory tripeptide), and GHK-Cu (a copper tripeptide associated with collagen synthesis). The Rx Peps Direct vial lists BPC-157 15mg, TB-500 15mg, KPV 15mg and GHK-Cu 50mg in 5mL. No published human trial has evaluated the complete four-peptide blend as one treatment.
- Is KLOW the same as the Wolverine Stack?
- No, and the distinction matters when comparing products. Wolverine Stack is the common name for BPC-157 plus TB-500 only, which Rx Peps Direct prescribes as a separate two-peptide vial. KLOW adds GHK-Cu and KPV to those two. KLOW also differs from GLOW, which contains BPC-157, TB-500 and GHK-Cu but not KPV. KPV is the ingredient that distinguishes KLOW from GLOW. No head-to-head human trial has established better outcomes for any of these blends over another.
- Why all four peptides together?
- Each ingredient has a separate proposed mechanism: BPC-157 in growth-factor signalling, TB-500 in cell migration, KPV in inflammatory tone, and GHK-Cu in collagen and elastin synthesis. Those mechanisms are drawn largely from laboratory and animal research, and combining them in one vial has not been shown in a controlled human study to work better than the ingredients used separately. Blends are also more expensive to compound, so KLOW sits among the higher-priced formulations.
- How is KLOW dosed?
- The prescription label and your prescriber's directions control the dose. KLOW is a fixed-ratio blend, so one volume sets all four doses at once and they cannot be adjusted individually. The listed starting protocol is 20 units subcutaneously, Monday to Friday: 20 units is 0.2mL, delivering 0.6mg BPC-157, 0.6mg TB-500, 0.6mg KPV and 2mg GHK-Cu. Per-ingredient dose ranges published for single-peptide vials do not transfer to this product and cannot be reproduced from it.
- How long should I take KLOW?
- No validated course length exists for this blend, so duration comes from your written prescription rather than from a standard protocol. Prescribers commonly treat it as episodic rather than continuous, in part because cumulative copper exposure from GHK-Cu and ongoing immune modulation are reasons for caution over long uninterrupted use. Your provider sets the cycle length and any breaks.
- Is KLOW allowed for tested athletes?
- No. BPC-157 is prohibited under WADA category S0 (non-approved substances) and thymosin beta-4 derivatives including TB-500 are prohibited under S2. Athletes subject to the WADA Code or another anti-doping programme should check the current prohibited list and their governing body before treatment.
- How is KLOW supplied?
- Compounded by a licensed U.S. 503A compounding pharmacy under a patient-specific prescription. Ships pre-reconstituted and ready to inject in cold-chain packaging. GHK-Cu contains copper, so a prepared solution often looks blue. Batches are tested by Eagle Analytical Services for sterility and bacterial endotoxin, and the Certificate of Analysis is published on this product page. Those two tests address microbial contamination; they do not establish ingredient identity, potency, purity or stability.
